Smith & Nephew Plc Stock price

Equities

SN.

GB0009223206

Medical Equipment, Supplies & Distribution

Market Closed - London Stock Exchange 11:35:29 2023-12-08 am EST Intraday chart for Smith & Nephew Plc 5-day change 1st Jan Change
1,048.5 GBX +1.75% +1.26% -5.50%
Sales 2023 * 5.54B Sales 2024 * 5.81B Capitalization 11.3B
Net income 2023 * 452M Net income 2024 * 614M EV / Sales 2023 *
2,50x
Net Debt 2023 * 2.54B Net Debt 2024 * 2.33B EV / Sales 2024 *
2,34x
P/E ratio 2023 *
26,5x
P/E ratio 2024 *
19,0x
Employees 19,000
Yield 2023 *
2,81%
Yield 2024 *
3,06%
Free-Float 99.31%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.99%
1 week+0.58%
Current month+1.76%
1 month+5.12%
3 months-2.39%
6 months-12.99%
Current year-6.13%
More quotes
1 week
1 015.00
Extreme 1015
1 046.50
1 month
983.20
Extreme 983.2
1 046.50
Current year
887.00
Extreme 887
1 316.75
1 year
887.00
Extreme 887
1 316.75
3 years
887.00
Extreme 887
1 681.50
5 years
887.00
Extreme 887
2 023.00
10 years
824.50
Extreme 824.5
2 023.00
More quotes
Managers TitleAgeSince
Chief Executive Officer - 2022
Director of Finance/CFO 52 2020
Compliance Officer - 1999
Members of the board TitleAgeSince
Director/Board Member 64 2017
Director/Board Member 59 2014
Director/Board Member 63 2020
More insiders
Date Price Change Volume
23-12-08 1,048.5 +1.75% 1 744 167
23-12-07 1,030.5 +0.19% 3,363,321
23-12-06 1,028.5 +0.29% 2,044,867
23-12-05 1,025.5 -0.77% 2,672,238
23-12-04 1,033.5 -0.19% 2,720,874

Delayed Quote London Stock Exchange, December 08, 2023 at 06:37 am EST

More quotes
Smith & Nephew Plc specializes in designing, manufacturing and marketing medical products and equipments. Net sales break down by activity sector as follows: - orthopedic surgery (40.5%): primarily orthopedic implants (hips, knees and shoulders) ; - sports medicine, arthroscopy and cervicofacial surgery (30.5%): surgery and damaged tissue repair products and instruments, visualization products, etc.; - wound care (29%): skin grafts for major burns victims, treatments for leg ulcers, etc. The United States accounts for 53% of net sales.
Calendar
More about the company
Trading Rating :
Investor Rating :
ESG Refinitiv :
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
12.96USD
Average target price
16.19USD
Spread / Average Target
+24.91%
Consensus
  1. Stock
  2. Equities
  3. Stock Smith & Nephew Plc - London Stock Exchange
The best tools reserved for subscribers to boost the performance of your investments!
Optimize my profits
fermer